Ind-Swift Ltd.

Name: Ind-Swift Ltd. Share Price Today, Stock Analysis
Brand: Ind-Swift Ltd.

Stock Card

NSE: INDSWFTLTD | BSE: 524652

₹15.76

₹0.91 (6.13%)

As on 13-Aug-2025IST

Market cap

₹85 Cr

Revenue (TTM)

₹515 Cr

P/E Ratio

0.3

P/B Ratio

-0.2

Div. Yield

0 %

Ind-Swift Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 15.15 High: 17.82

52 Week Range

Low: 12.00 High: 34.70

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹283 Cr
ROE

0 %
ROCE

26 %
Industry P/E

44.31
EV/EBITDA

12.6
Debt to Equity

-2.1
Book Value

₹--
EPS

₹2.9
Face value

2
Shares outstanding

54,164,653

10 Years Aggregate

CFO

₹270.68 Cr

EBITDA

₹-74.64 Cr

Net Profit

₹-783.96 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Ind-Swift	-52.3	-5.0	21.9	-36.5	16.6	40.8	11.6
BSE Healthcare^*	10.2	10.3	11.1	13.4	28.1	14.5	12.1

As on 13-Aug-2025 | *As on 21-May-2026

Company	2024	2023	2022	2021	2020	2019	2018
Ind-Swift	83.6	43.9	-0.4	226.7	26.2	-54.5	-38.4
BSE Small Cap	29.0	47.5	-1.8	62.8	32.1	-6.8	-23.4
BSE Healthcare	43.1	37.0	-12.1	20.9	61.4	-3.5	-5.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

News & Analysis

All News

In Focus: Growth Pills

2 min read•By Value Research

Magnun Pharma Fund

2 min read•By Research Desk

About Ind-Swift

Ind-Swift Limited develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. The company offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective,... cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names. It also offers medicines for various therapeutic comprising gynaecology, pediatrics, dermatology, and other generic medicines under the Anin, Suprox, Cozy, Distone, and Oliade name. In addition, the company provides antibiotic, anti-cold, nutraceuticals, anti-diarrhoeal, anti-malarial, anti-depressants, cardiology, diabetology, anti-depressant, anti-allergic, anti- infective, neurology, and oncology. Ind-Swift Limited provides Ayurvedic products, as well as contract research and manufacturing services. The company exports its products, as well as licenses its products to Europe, Australia, Canada, South Africa, and Russia. Swift Limited was founded in 1983 and is based in Chandigarh, India. Read more